Cannabis research has moved beyond its use as an illegal recreational drug. Increasingly, focus is on its potential as a therapeutic substance, particularly in serious chronic illnesses such as multiple sclerosis.
This new title describes current research findings relating to the medicinal use of cannabis and cannabinoids. Topics covered include the pharmacology, formulation, safety and efficacy of cannabis as a therapeutic agent; growth and breeding of cannabis as a medicine; cannabis for neuropathic pain treatment and for multiple sclerosis; clinical studies and the development of cannabis-based medicine; and forensic and international control of cannabis.
Written by experts in the UK and USA, this is an essential reference for pharmacists, doctors, pharmacologists and all other healthcare professionals with an interest in cannabis-derived medicines for symptom relief of intractable diseases.Edited by
- Geoffrey W Guy - Executive Chairman, GW Pharmaceuticals, UK
- Brian A Whittle - Scientific Director
- Philip J Robson - Medical Director, GW Pharmaceuticals, UK
GW Pharmaceuticals: Research & Development
GW's research explores the potential therapeutic applications of cannabinoids and the endocannabinoid system across a wide range of disease areas. http://www.gwpharm.com/r-and-d.aspx